Judge: Investor’s Stock-Drop Claims Against Alzheimer Drug Maker Miss The Mark
BOSTON — A federal judge in Massachusetts ruled that dismissal of federal securities law claims in a class action against a biotechnology company and certain of its current and former senior...To view the full article, register now.
Already a subscriber? Click here to view full article